Merz Pharma makes new investment in Cytrellis Biosystems
Merz Pharma has made a strategic venture investment in Cytrellis Biosystems, a US based company developing a new class of non-surgical products to combat sagging skin associated with ageing. Merz has joined a growing set of industry investors to back Boston-based Cytrellis Biosystems. The investment emphasizes Merz’ strategy to allocate
